Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP608022.RA7LSFxDNtZwo5HJLmzrIcdNlmnynAHqzNC64_Nmuo2Tw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP608022.RA7LSFxDNtZwo5HJLmzrIcdNlmnynAHqzNC64_Nmuo2Tw130_assertion type Assertion NP608022.RA7LSFxDNtZwo5HJLmzrIcdNlmnynAHqzNC64_Nmuo2Tw130_head.
- NP608022.RA7LSFxDNtZwo5HJLmzrIcdNlmnynAHqzNC64_Nmuo2Tw130_assertion description "[The aspartic protease cathepsin D, a poor prognostic indicator of breast cancer, is abundantly secreted as procathepsin D by human breast cancer cells and self-activates at low pH in vitro, giving rise to catalytically active cathepsin D. Due to a lower extracellular pH in tumor microenvironments compared to normal tissues, cathepsin D may cleave pathophysiological substrates contributing to cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608022.RA7LSFxDNtZwo5HJLmzrIcdNlmnynAHqzNC64_Nmuo2Tw130_provenance.
- NP608022.RA7LSFxDNtZwo5HJLmzrIcdNlmnynAHqzNC64_Nmuo2Tw130_assertion evidence source_evidence_literature NP608022.RA7LSFxDNtZwo5HJLmzrIcdNlmnynAHqzNC64_Nmuo2Tw130_provenance.
- NP608022.RA7LSFxDNtZwo5HJLmzrIcdNlmnynAHqzNC64_Nmuo2Tw130_assertion SIO_000772 22898924 NP608022.RA7LSFxDNtZwo5HJLmzrIcdNlmnynAHqzNC64_Nmuo2Tw130_provenance.
- NP608022.RA7LSFxDNtZwo5HJLmzrIcdNlmnynAHqzNC64_Nmuo2Tw130_assertion wasDerivedFrom befree-20140225 NP608022.RA7LSFxDNtZwo5HJLmzrIcdNlmnynAHqzNC64_Nmuo2Tw130_provenance.
- NP608022.RA7LSFxDNtZwo5HJLmzrIcdNlmnynAHqzNC64_Nmuo2Tw130_assertion wasGeneratedBy ECO_0000203 NP608022.RA7LSFxDNtZwo5HJLmzrIcdNlmnynAHqzNC64_Nmuo2Tw130_provenance.